The impact of carvedilol coadministration on enantioselective lercanidipine pharmacokinetics in patients with chronic kidney disease

被引：0
|
作者：
Schaab, Estela H.
Lanchote, Vera L.
Paiva, Carlos E. [1 ]
Dantas, Marcio [1 ]
Coelho, Eduardo B. [1 ]
机构：
[1] Univ Sao Paulo, Med Clin, BR-14049 Ribeirao Preto, Brazil
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2011年 / 51卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1358 / 1358
页数：1
相关论文
共 50 条
  • [41] There Is No Impact of Diabetes on the Endothelial Function of Chronic Kidney Disease Patients
    Coutinho, Mariana Nogueira
    Carvalho, Aluizio Barbosa
    Dalboni, Maria Aparecida
    Mouro, Margaret Gori
    Suemitsu Higa, Elisa Mieko
    Costa-Hong, Valeria
    Bortolotto, Luiz Aparecido
    de Oliveira Figueiredo, Rejane Augusta
    Fernandes Canziani, Maria Eugenia
    JOURNAL OF DIABETES RESEARCH, 2018, 2018
  • [42] IMPACT OF AN ADAPTED PHYSICAL ACTIVITY FOR PATIENTS WITH CHRONIC KIDNEY DISEASE
    Frih, Bechir
    Frih, Ameur
    Ben Salah, Rim
    Rjili, Hamza
    Ben Salah, Zohra
    Ben Dhia, Nacer
    El May, Mezri
    Hammami, Mohamed
    ACTA PHYSIOLOGICA, 2015, 214 : 48 - 49
  • [43] The Impact of Systemic Calcified Atherosclerosis in Patients With Chronic Kidney Disease
    McCullough, Peter A.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2008, 15 (04) : 335 - 337
  • [44] Impact of visceral fat area in patients with chronic kidney disease
    Shun Manabe
    Hiroshi Kataoka
    Toshio Mochizuki
    Kazuhiro Iwadoh
    Yusuke Ushio
    Keiko Kawachi
    Kentaro Watanabe
    Saki Watanabe
    Taro Akihisa
    Shiho Makabe
    Masayo Sato
    Naomi Iwasa
    Rie Yoshida
    Yukako Sawara
    Norio Hanafusa
    Ken Tsuchiya
    Kosaku Nitta
    Clinical and Experimental Nephrology, 2021, 25 : 608 - 620
  • [45] Impact of visceral fat area in patients with chronic kidney disease
    Manabe, Shun
    Kataoka, Hiroshi
    Mochizuki, Toshio
    Iwadoh, Kazuhiro
    Ushio, Yusuke
    Kawachi, Keiko
    Watanabe, Kentaro
    Watanabe, Saki
    Akihisa, Taro
    Makabe, Shiho
    Sato, Masayo
    Iwasa, Naomi
    Yoshida, Rie
    Sawara, Yukako
    Hanafusa, Norio
    Tsuchiya, Ken
    Nitta, Kosaku
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (06) : 608 - 620
  • [46] Impact of Chronic Kidney Disease on Echocardiographic Parameters in Patients with Chronic Heart Failure
    Hu, Danfeng
    Shi, Chuan
    Li, Jinping
    CIRCULATION, 2010, 122 (02) : E131 - E132
  • [47] Modeling Metformin and Dapagliflozin Pharmacokinetics in Chronic Kidney Disease
    Shahidehpour, Andrew
    Rashid, Mudassir
    Askari, Mohammad Reza
    Ahmadasas, Mohammad
    Abdel-Latif, Mahmoud
    Fritschi, Cynthia
    Quinn, Lauretta
    Reutrakul, Sirimon
    Bronas, Ulf G.
    Cinar, Ali
    AAPS JOURNAL, 2024, 26 (05):
  • [48] Pharmacokinetics and safety of panitumumab in a patient with chronic kidney disease
    Krens, L. L.
    Baas, J. M.
    Guchelaar, H. J.
    Gelderblom, H.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (01) : 179 - 182
  • [49] Pharmacokinetics and safety of panitumumab in a patient with chronic kidney disease
    L. L. Krens
    J. M. Baas
    H. J. Guchelaar
    H. Gelderblom
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 179 - 182
  • [50] PHARMACOKINETICS AND EFFICACY OF CARVEDILOL IN HYPERTENSIVE PATIENTS WITH CHRONIC-RENAL-FAILURE AND HEMODIALYSIS-PATIENTS
    MASUMURA, H
    MIKI, S
    KAIFU, Y
    KITAJIMA, W
    ABE, Y
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 19 : S102 - S107
12345